Finally, using a mouse model of intraperitoneal disseminated tumor lesions mimicking late-stage ovarian cancer, the advantage of fluorescence guidance with the anti-HER2 nanobody tracer 2Rs15d-IRDye800CW on the efficiency of debulking surgery was demonstrated. This evidence concerns the gene ERBB2 and ovarian carcinoma.